The word was chosen by an advisory panel of language experts Kritika Agrawal, Poonam Nigam Sahay and Imogen Foxell.
'Cyrus was always very different. He would think before acting.'
'After the discovery of the biomarkers, Calpain and Inflammasomes, we know we have a biomarker to target.' 'That way, we can use the biomarkers for an early diagnosis of blood clotting due to hypoxia or low oxygen in the tissues, and can save a life.'
The government on Friday warned about the declining compliance to mask usage in the country amid concerns over the Omicron variant of the coronavirus and urged people to follow COVID-appropriate behaviour and get vaccinated to prevent surge in cases.
Only 10 per cent of stocks account for 93 per cent of investments.
Every year, BioSingapore receives nominations from biotechnology industry associations, industry peers, academics and institutions across Asia-Pacific for the most outstanding companies or individuals in various categories. The nominees are judged by a panel of distinguished leaders in the field.
Responding to another question, Choubey said that the phase-I of clinical trials have revealed excellent safety of the two candidate vaccines indigenously developed by Bharat Biotech in collaboration with Indian Council of Medical Research and Cadila Healthcare Ltd, and now their immunogenicity testing is in progress. Their phase II clinical trials are ongoing.
As a proactive step, the government has already placed nations, where this VoC has been found, in the category of 'at risk' countries for additional follow-up measures of international travellers coming into lndia from these destinations, he said in a letter dated November 27.
Prime Minister Narendra Modi was on Saturday briefed about the new 'Omicron' variant of the coronavirus, and he asked officials to review the plans to ease international travel restrictions in light of the 'emerging new evidence.'
The aim of the mission is to accelerate the development of at least six vaccine candidates and ensure that they are licenced and introduced in market for emergency use at the earliest.
In a virtual conference from Moscow, Dmitriev said Sputnik V is not only 'one of the most effective' but also among the 'affordable' vaccines in the world.
The Government of India's Department of Biotechnology offers Assocatiateship for Young Scientists 2007-2008
Of the 23.9 million vaccinators who provide vaccination under the universal immunisation programme, 15.4 million will be used for Covid vaccination.
More than 6 crore doses of COVID-19 vaccine have been sent to 76 nations, while 4.5 crore doses have been administered to beneficiaries in the country till now, Union Health Minister Harsh Vardhan said.
Taking lessons from that, I would think seamless digital payments is something you have to clearly have a roadmap for, the FM said.
While Karnataka reported five new cases, Delhi and Telangana reported four each, and Gujarat reported one fresh case of the Omicron variant.
Bharti Airtel was the top gainer in the Sensex pack, rallying around 11 per cent, followed by ONGC, UltraTech Cement, ITC, PowerGrid and NTPC. On the other hand, IndusInd Bank, Reliance Industries, L&T and SBI were among the laggards.
Foreign portfolio investors (FPIs) have pumped in a whopping $33.8 billion into domestic equities and debt till February 15 this fiscal year -- the highest since FY15 when it was nearly $46 billion --taking their net outstanding investments to a record $592.5 billion, as per a report. Of the total FPI assets of $592.5 billion, $537.4 billion were in equities and $51.38 billion in debt, according to the data collated by Care Ratings. The maximum holding is in financial services sector at $191.3 billion, followed by software ($76.1 billion), oil & gas ($50 billion), automobiles & auto components ($26.9 billion, pharmaceuticals & biotechnology ($22.8 billion), sovereign ($21.7 billion--debt), household & personal products ($20.2 billion), capital goods ($19.8 billion), food, beverages & tobacco ($15.7 billion) and insurance ($13.4 billion).
DCGI has approved to market Itolizumab (ALZUMAb) injection 25mg and 5mL solution for emergency use in India for the treatment of cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) patients due to COVID-19, Biocon said in a release.
Department of Biotechnology offers post-graduate students the chance to train with the top Biotech companies in India.
'There is no emergency of a third wave that we are rushing for booster doses.'
a team led by ecologist Uma Ramakrishnan and her student Vinay Sagar from the National Centre for Biological Sciences, Bangalore, have discovered that the coat colouration and patterning which make the wild cats appear dark boil down to a single mutation
Presentations were given by the Department of Science and Technology, Department of Biotechnology, Council of Scientific and Industrial Research (CSIR) and the principal scientific adviser to the government before the Parliamentary Standing Committee on Science and Technology, Environment and Climate on the Centre's COVID-19 preparedness.
The Indian government and private firms have stepped up efforts to develop a vaccine to halt the spread of COVID-19 which has claimed over 3,700 lives with more than 1,25,000 cases in the country.
The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research published in The Lancet journal.
Currently, the country is using two 'made-in India' jabs -- Covishield and Covaxin -- to inoculate its billion-plus population and has administered 20 crore doses since launching the world's largest vaccination drive in mid-January. A third vaccine, Russian-made Sputnik V, has been approved by the government and is being used on a smaller scale at present.
The move is expected to create space for more budding entrepreneurs in the country to be eligible for self-certification, relaxed public procurement norms, rebate in patent filing, start-up funding, investment and easier closure compliance.
The foreign envoys were taken to Hyderabad over a month after the ministry of external affairs briefed over 190 heads of diplomatic missions and representatives of leading international organisations on COVID-19 related issues.
Biotechnology major Biocon on Tuesday said it aims to achieve revenues of $1 billion in the next three years.
The joint secretary also said a high-level task force to work on frontiers of science related to vaccines and drug testing was formed on Sunday.
Noting that the biotechnology industry in Asia is still at a nascent stage, India has announced the launch of an annual 'Asia Biotech' meet.
The company has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome in moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19.
'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'
American business tycoon and philanthropist Bill Gates, co-chair of the Bill and Melinda Gates Foundation on Friday announced an emergency relief fund of $700,000 for the flood victims of Jammu and Kashmir.
The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added.
While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed.
This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.
An association of biotechnology scientists on Wednesday appealed to the Centre to approve Bt brinjal for commercial cultivation "without further delay" for the benefit of Indian farmers and consumers.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances